Click here to sign in with or
by Erin Matthews, Canadian Light Source
Researchers from Western University have developed a material that could eventually improve the way drugs are administered to patients, by allowing doctors to "see" exactly whether drugs are reaching the targets and working properly.
By combining a material already used to deliver medication to specific sites in the body with another that glows in the dark (optical probe), Assistant Professor Lijia Liu and graduate student Ellie W.T Shiu have created a composite that can be used to track the path of a drug carrier through the human body. In the short term, the new approach could be used to monitor medication used for cancer and bone diseases—but it could eventually have a wide range of therapeutic applications.
With the help of the Canadian Light Source (CLS) at the University of Saskatchewan (USask), Shiu and Liu were able to see the interaction between the luminescent optical system and the drug carrier. Their findings were recently published in the journal Physical Chemistry Chemical Physics.
"Our optical probe is kind of like glow-in-the-dark paint or when you walk into a club wearing those [glow-stick] bracelets, and you can still see the light," says Liu.
The probe designed by Liu and Shiu emits near infrared light and can be tracked by standard bioimaging techniques. This system is safer than other probes which need a source of radiation to produce light.
This impressive research began as an undergraduate project for Shiu, who is currently a master's student in Liu's lab. Shiu was able to collaborate with CLS scientists who helped her conduct experiments remotely.
"I did gain a lot of insight from the meaningful conversations with the scientists at the CLS," says Shiu.
There are elements of Liu and Shiu's research that cannot be achieved without the use of synchrotron technology.
"There is one particular technique that can only be done at a synchrotron, and that piece of the puzzle is very important in terms of understanding the structure of our materials," says Liu. Explore further Scientists improve yield predictions based on seedling data More information: Wai-Tung Shiu et al, Synthesis and characterization of a near-infrared persistent luminescent Cr-doped zinc gallate–calcium phosphate composite, Physical Chemistry Chemical Physics (2022). DOI: 10.1039/D2CP03431J Journal information: Physical Chemistry Chemical Physics
Provided by Canadian Light Source Citation: New glow-in-the-dark material can track path of drugs through the human body (2022, September 22) retrieved 24 September 2022 from https://phys.org/news/2022-09-glow-in-the-dark-material-track-path-drugs.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties.
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.